Send me real-time posts from this site at my email

Biogen Price Target

Analysts were quick to rank Biogen $BIIB a hold or sell. Some dared call the stock a buy. Per tipranks, use the success rate to check which analyst to take seriously.

Tipranks /5 Rating Price Target Analyst Firm Success Rate
2.1 Hold $236 Guggenheim 49%
4.8 Hold $250 BMO Capital 54%
4 Hold $250 Jefferies 51%
3.6 Hold $242 UBS 43%
4.5 Sell $210 Morgan Stanley 60%
4.5 Hold $250 Cantor Fitzgerald 49%
4.1 Hold $250.00 Barclays 56%
4.8 Hold $233 Stifel Nicolaus 58%
1.9 Hold $244 J.P. Morgan 41%
4.7 Hold $275 Merrill Lynch 73%
4.4 Hold $286 Goldman Sachs 62%
4.5 Buy $320 Nomura 50%
4.6 Buy $275.00 Cowen & Co. 51%
4.2 Hold $230 Citigroup 53%
4.5 Hold $250 Robert W. Baird 56%
1.3 Hold $275 Canaccord Genuity 39%
4.8 Buy $280 Piper Jaffray 58%
2.1 Hold $325 Guggenheim 49%

$GS at a 4.4 rating has a hold and $286 PT:

$BIIB, BIOGEN INC / H1

No chart action or valuation will be of use at this time to set a PT on Biogen. The Value Stock group is neutral for now.

Biotech picks $XBIT and $DERM are March's Picks:

$DERM, DERMIRA INC / H1

XBIT did well for subscribers and members (requires subscription):

$XBIT, XBIOTECH INC / H1

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue